Standardized molecular analyses of glioma EVS

Ended Project Grant Awarded Last action

Award ID
R01CA237500
Recipient
Awarding agency
Obligated
$3,012,122

Award facts

Assistance listing
93.394 Cancer Detection and Diagnosis Research
Completion date
Originally
Place of performance
Massachusetts, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $557,524
Amendment $577,860
Amendment $602,790
Amendment Standardized molecular analyses of glioma EVS - extracellular vesicles (EVS) have emerged as a promising surrogate for tissue biopsy, potentially enabling… $624,914
Original award $649,034

Subawards

Subrecipient Amount Awarded
Exosome Diagnostics Inc. The main objective of this collaborative proposal is to optimize assays and technology to purify and characterize cancer specific extracellular vesicles,… $136,037

Quick answers

Who received award R01CA237500?

R01CA237500 was awarded to The General Hospital Corporation by National Cancer Institute (National Institutes of Health) on June 16, 2020.

How much is award R01CA237500 worth?

$3,012,122 has been obligated on R01CA237500.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award